Gibbons J C, Williams S J
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, NSW, Australia.
J Gastroenterol Hepatol. 1998 Feb;13(2):116-24. doi: 10.1111/j.1440-1746.1998.tb00625.x.
Benign biliary strictures can now be effectively treated with endoscopic therapy in a variety of clinical situations. Despite recent developments in imaging techniques (endoscopic ultrasound and magnetic resonance imaging), it is often difficult to differentiate benign from malignant biliary strictures. The sensitivity of tissue diagnosis (cytology and needle biopsy) at endoscopic retrograde cholangiopancreatography (ERCP) remains poor (40-50%), and further diagnostic methods are required. Endoscopic therapy offers a definitive treatment in 70-90% of patients following post-operative biliary stricture, including anastomotic strictures following liver transplant. Endoscopic therapy successfully achieves symptomatic, biochemical, and cholangiographic response, and may improve survival in patients with primary sclerosing cholangitis. Strictures secondary to chronic pancreatitis are resistant to standard endoscopic therapy and metallic endoprotheses have been trialed with varying success. Endoscopic therapy is technically difficult and should be performed in specialized centres using a multidisciplinary approach.
在多种临床情况下,良性胆管狭窄现在可以通过内镜治疗得到有效处理。尽管成像技术(内镜超声和磁共振成像)最近有所发展,但区分良性和恶性胆管狭窄往往仍很困难。内镜逆行胰胆管造影术(ERCP)时组织诊断(细胞学和针吸活检)的敏感性仍然较低(40%-50%),因此需要进一步的诊断方法。对于术后胆管狭窄患者,包括肝移植术后的吻合口狭窄,内镜治疗能为70%-90%的患者提供确定性治疗。内镜治疗成功实现了症状、生化指标及胆管造影方面的改善,并且可能提高原发性硬化性胆管炎患者的生存率。慢性胰腺炎继发的狭窄对标准内镜治疗有抵抗性,金属内支架已进行了试验,效果不一。内镜治疗技术难度大,应在专业中心采用多学科方法进行。